Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation

被引:91
作者
Alexander, JH
Sparapani, RA
Mahaffey, KW
Deckers, JW
Newby, LK
Ohman, EM
Corbalán, R
Chierchia, SL
Boland, JB
Simoons, ML
Califf, RM
Topol, EJ
Harrington, RA
机构
[1] Duke Clin Res Inst, Durham, NC 27715 USA
[2] Catholic Univ Chile, Santiago, Chile
[3] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy
[4] Hop Citadelle, Liege, Belgium
[5] Cardialysis, Rotterdam, Netherlands
[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 283卷 / 03期
关键词
D O I
10.1001/jama.283.3.347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Controversy surrounds the diagnostic and prognostic importance of slightly elevated cardiac markers in patients with acute coronary syndromes without ST-segment elevation. Objectives To investigate the relationship between peak creatine kinase (CK)-MB level and outcome and to determine whether a threshold CK-MB level exists below which risk is not increased. Design and Setting Retrospective observational analysis of data from the international Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial, conducted from November 1995 to January 1997, Patients A total of 8250 patients with acute coronary sydromes without ST-segment elevation who had at least 1 CK-MB sample collected during their index hospitalization. Main Outcome Measure Mortality at 30 days and 6 months, was assessed by category of index-hospitalization peak CK-MB level (0-1, >1-2, >2-3, >3-5, >5-10, or >10 times the upper limit of normal). Multivariable logistic regression was used to determine the independent prognostic significance of peak CK-MB level after adjustment for baseline predictors of 30-day and 6-month mortality. Results Mortality at 30 days and 6 months increased from 1.8% and 4.0%, respectively, in patients with normal peak CK-MB levels, to 3.3% and 6.2% at peak CK-MB levels 1 to 2 times normal, to 5.1% and 7.5% at peak CK-MB levels 3 to 5 times normal, and to 8.3% and 11.0% at peak CK-MB levels greater than 10 times normal. Log-transformed peak CK-MB levels were predictive of adjusted 30-day and 6-month mortality (P<.001 for both). Conclusions Our data show that elevation of CK-MB level is strongly related to mortality in patients with acute coronary syndromes without ST-segment elevation, and that the increased risk begins with CK-MB levels just above normal. in the appropriate clinical context, even minor CK-MB elevations should be considered indicative of myocardial infarction.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 46 条
[1]   Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions [J].
Abdelmeguid, AE ;
Topol, EJ ;
Whitlow, PL ;
Sapp, SK ;
Ellis, SG .
CIRCULATION, 1996, 94 (07) :1528-1536
[2]   BIOCHEMICAL MARKERS OF MYOCARDIAL INJURY - IS MB CREATINE-KINASE THE CHOICE FOR THE 1990S [J].
ADAMS, JE ;
ABENDSCHEIN, DR ;
JAFFE, AS .
CIRCULATION, 1993, 88 (02) :750-763
[3]  
Adgey AAJ, 1999, CLIN CARDIOL, V22, P257
[4]   ASSOCIATION OF INCREASED PLASMA MB CPK ACTIVITY AND IRREVERSIBLE ISCHEMIC MYOCARDIAL INJURY IN DOG [J].
AHMED, SA ;
WILLIAMSON, JR ;
ROBERTS, R ;
CLARK, RE ;
SOBEL, BE .
CIRCULATION, 1976, 54 (02) :187-192
[5]   Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes [J].
Antman, EM ;
Tanasijevic, MJ ;
Thompson, B ;
Schactman, M ;
McCabe, CH ;
Cannon, CP ;
Fischer, GA ;
Fung, AY ;
Thompson, C ;
Wybenga, D ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) :1342-1349
[6]   PROGNOSTIC-SIGNIFICANCE OF NONFATAL MYOCARDIAL REINFARCTION [J].
BENHORIN, J ;
MOSS, AJ ;
OAKES, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (02) :253-258
[7]  
BITTL JA, 1985, J BIOL CHEM, V260, P208
[8]   INFARCT SIZE ESTIMATED FROM SERIAL SERUM CREATINE-PHOSPHOKINASE IN RELATION TO LEFT-VENTRICULAR HEMODYNAMICS [J].
BLEIFELD, W ;
MATHEY, D ;
HANRATH, P ;
BUSS, H ;
EFFERT, S .
CIRCULATION, 1977, 55 (02) :303-311
[9]  
Boersma Eric, 1999, Journal of the American College of Cardiology, V33, p359A
[10]   Myonecrosis after revascularization procedures [J].
Califf, RM ;
Abdelmeguid, AE ;
Kuntz, RE ;
Popma, JJ ;
Davidson, CJ ;
Cohen, EA ;
Kleiman, NS ;
Mahaffey, KW ;
Topol, EJ ;
Pepine, CJ ;
Lipicky, RJ ;
Granger, CB ;
Harrington, RA ;
Tardiff, BE ;
Crenshaw, BS ;
Bauman, RP ;
Zuckerman, BD ;
Chaitman, BR ;
Bittl, JA ;
Ohman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :241-251